These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 16266820)

  • 1. Screening for distant metastases in patients with head and neck cancer: is there a role for (18)FDG-PET?
    Brouwer J; Senft A; de Bree R; Comans EF; Golding RP; Castelijns JA; Hoekstra OS; Leemans CR
    Oral Oncol; 2006 Mar; 42(3):275-80. PubMed ID: 16266820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FDG-PET and detection of distant metastases and simultaneous tumors in head and neck squamous cell carcinoma: a comparison with chest radiography and chest CT.
    Krabbe CA; Pruim J; van der Laan BF; Rödiger LA; Roodenburg JL
    Oral Oncol; 2009 Mar; 45(3):234-40. PubMed ID: 18715818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chest CT and whole-body 18F-FDG PET are cost-effective in screening for distant metastases in head and neck cancer patients.
    Uyl-de Groot CA; Senft A; de Bree R; Leemans CR; Hoekstra OS
    J Nucl Med; 2010 Feb; 51(2):176-82. PubMed ID: 20124045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for distant metastases in head and neck cancer patients by chest CT or whole body FDG-PET: a prospective multicenter trial.
    Senft A; de Bree R; Hoekstra OS; Kuik DJ; Golding RP; Oyen WJ; Pruim J; van den Hoogen FJ; Roodenburg JL; Leemans CR
    Radiother Oncol; 2008 May; 87(2):221-9. PubMed ID: 18410977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chest radiography or chest CT plus head and neck CT versus
    Kim Y; Roh JL; Kim JS; Lee JH; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2019 Jan; 88():109-114. PubMed ID: 30616780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of (18)F-FDG PET/CT for the detection of distant metastases in high-risk patients with head and neck squamous cell carcinoma.
    Haerle SK; Schmid DT; Ahmad N; Hany TF; Stoeckli SJ
    Oral Oncol; 2011 Jul; 47(7):653-9. PubMed ID: 21658990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for distant metastases in head and neck cancer patients using FDG-PET and chest CT: validation of an algorithm.
    Senft A; Hoekstra OS; Witte BI; Leemans CR; de Bree R
    Eur Arch Otorhinolaryngol; 2016 Sep; 273(9):2643-50. PubMed ID: 26350882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of FDG-PET/CT on the management of head and neck tumours: the radiotherapist's perspective.
    Dietl B; Marienhagen J; Kühnel T; Schreyer A; Kölbl O
    Oral Oncol; 2008 May; 44(5):504-8. PubMed ID: 17826307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of 18F-FDG PET in the detection of stage M0 carcinoma of the nasopharynx.
    Yen TC; Chang JT; Ng SH; Chang YC; Chan SC; Lin KJ; Lin WJ; Fu YK; Lin CY
    J Nucl Med; 2005 Mar; 46(3):405-10. PubMed ID: 15750151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-FDG PET/CT for detecting distant metastases in patients with recurrent head and neck squamous cell carcinoma.
    Yi JS; Kim JS; Lee JH; Choi SH; Nam SY; Kim SY; Roh JL
    J Surg Oncol; 2012 Nov; 106(6):708-12. PubMed ID: 22674652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Staging of head and neck squamous cell cancer with extended-field FDG-PET.
    Schwartz DL; Rajendran J; Yueh B; Coltrera M; Anzai Y; Krohn K; Eary J
    Arch Otolaryngol Head Neck Surg; 2003 Nov; 129(11):1173-8. PubMed ID: 14623746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-body (18)F-fluorodeoxyglucose positron emission tomography in patients with head and neck cancer.
    Kitagawa Y; Nishizawa S; Sano K; Sadato N; Maruta Y; Ogasawara T; Nakamura M; Yonekura Y
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 Feb; 93(2):202-7. PubMed ID: 11862212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative evaluation of patients with primary head and neck cancer using dual-head 18fluorodeoxyglucose positron emission tomography.
    Stokkel MP; ten Broek FW; Hordijk GJ; Koole R; van Rijk PP
    Ann Surg; 2000 Feb; 231(2):229-34. PubMed ID: 10674615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of unknown primary tumours and distant metastases in patients with cervical metastases: value of FDG-PET versus conventional modalities.
    Regelink G; Brouwer J; de Bree R; Pruim J; van der Laan BF; Vaalburg W; Hoekstra OS; Comans EF; Vissink A; Leemans CR; Roodenburg JL
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1024-30. PubMed ID: 12173016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical values for abnormal ¹⁸F-FDG uptake in the head and neck region of patients with head and neck squamous cell carcinoma.
    Lee HS; Kim JS; Roh JL; Choi SH; Nam SY; Kim SY
    Eur J Radiol; 2014 Aug; 83(8):1455-60. PubMed ID: 24929443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors.
    Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2009 Mar; 45(3):218-24. PubMed ID: 18804404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential for truncating the scan length of restaging FDG-PET/CT after chemoradiotherapy in head and neck squamous cell carcinoma.
    Huang YT; Ravi Kumar AS
    Nucl Med Commun; 2012 May; 33(5):503-8. PubMed ID: 22262244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of occult bone metastases from head and neck squamous cell carcinoma: impact of positron emission tomography computed tomography with fluorodeoxyglucose F 18.
    Basu D; Siegel BA; McDonald DJ; Nussenbaum B
    Arch Otolaryngol Head Neck Surg; 2007 Aug; 133(8):801-5. PubMed ID: 17709620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of distant metastases with positron-emission tomography-computed tomography in patients with previously untreated head and neck cancer.
    Gourin CG; Watts TL; Williams HT; Patel VS; Bilodeau PA; Coleman TA
    Laryngoscope; 2008 Apr; 118(4):671-5. PubMed ID: 18197136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The adverse impact of surveillance intervals on the sensitivity of FDG-PET/CT for the detection of distant metastases in head and neck cancer patients.
    Senft A; Yildirim G; Hoekstra OS; Castelijns JA; René Leemans C; de Bree R
    Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):1113-1120. PubMed ID: 27804082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.